C Share Conversion

The MedicX Fund Limited
10 December 2007


For immediate release                                           10 December 2007





                              MedicX Fund Limited
                  ('MedicX Fund', 'the Fund' or 'the Company')





                               C Share Conversion





MedicX Fund, (LSE: MXF, LSE: MXFC), the specialist investor in modern purpose
built primary healthcare properties, today announces details of the conversion
of C shares to Ordinary shares.



Further to the Company's announcement on 1 October 2007 that the Calculation
Time for the conversion of C Shares into Ordinary Shares  was 30 September 2007,
the Board of Directors has determined that the C Shares will convert into
Ordinary Shares on the opening of business on 12 December (the 'Conversion
Time').   The Ordinary Shares arising on Conversion will rank in full for all
dividends and other distributions declared, made or paid and otherwise pari
passu with the Ordinary Shares already in issue at the Conversion Time.



Net Asset Values as at 30 September 2007


Ordinary Share adjusted net asset value1                   96.96 pence per share
C Share Share adjusted net asset value1                    96.87 pence per share





1 Adjusted to exclude goodwill and the impact of deferred tax not expected to
crystallise



Conversion Ratio



The Directors have considered the calculation of the Conversion ratio and,
having taken account of any adjustments that are considered appropriate by the
Directors, the Conversion Ratio for the Conversion of the C Shares is 1.0000
Ordinary Shares for every one C Share. This calculation has been reviewed by the
Company's auditors.



Other matters



Fractions of Ordinary Shares arising on Conversion will not be allocated to
holders of C Shares but will be aggregated and sold for the benefit of the
Company. Following Conversion, the Company will have 79,621,215 Ordinary Shares
in issue.



Application has been made to the UK Listing Authority for the 22,160,500
Ordinary Shares arising on Conversion to be admitted to the Official List. An
application has been made to the London Stock Exchange for the same number of
Ordinary Shares to be admitted to trading on the London Stock Exchange. The C
Shares are to be permanently removed from the trading on the London Stock
Exchange at close of business on 11 December 2007.  Trading in the converted
Ordinary Shares is expected to commence at 8.00.am on 12 December 2007.



Certificates for the Ordinary Shares arising on Conversion are expected to be
despatched within 5 business days of the conversion date.



All terms used in this announcement are defined as set out in the Prospectus
dated 2 May 2007.



                                      End

For further information please contact:


MedicX Fund                                                  [phone]
Alison Simpson, Director

MedicX Group                                                 [phone]
Keith Maddin, Chairman
Mike Adams, Managing Director

Buchanan Communications                                     [phone]
Charles Ryland / Lisa Baderoon / Mary-Jane Johnson






                      This information is provided by RNS
            The company news service from the London Stock Exchange      CONMGMGZLLFGNZM